<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    PTC Therapeutics, Inc.

    PTC Therapeutics, Inc.

    PTC is a science-led, global biopharmaceutical company focused on the discovery, d...

    PTC is a science-led, global biopharmaceutical ...

    Filing Type:    PU
    Milestone Pharmaceuticals Inc.

    Milestone Pharmaceuticals Inc.

    We are a patient-centric, clinical-stage biopharmaceutical company dedicated to br...

    We are a patient-centric, clinical-stage biopha...

    Filing Type:    PU
    Alexion Pharmaceuticals, Inc.

    Alexion Pharmaceuticals, Inc.

    Alexion (NASDAQ: ALXN) is a global biopharmaceutical company focused on serving pa...

    Alexion (NASDAQ: ALXN) is a global biopharmaceu...

    Filing Type:    PU
    BioLife Solutions, Inc.

    BioLife Solutions, Inc.

    BioLife Solutions is the leading developer, manufacturer and supplier of proprieta...

    BioLife Solutions is the leading developer, man...

    Filing Type:    PU
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Bio-Techne Corp

    Bio-Techne Corp

    Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of h...

    Bio-Techne Corporation (NASDAQ: TECH) is a lead...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    BeyondSpring, Inc.

    BeyondSpring, Inc.

    Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-...

    Headquartered in New York, BeyondSpring Inc. (B...

    Filing Type:    PU
    Verastem, Inc.

    Verastem, Inc.

    Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committ...

    Verastem Oncology (Nasdaq: VSTM) is a commercia...

    Filing Type:    PU
    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc.

    Checkpoint Therapeutics, Inc. (“Checkpoint”) is a clinical-stage, immuno-oncol...

    Checkpoint Therapeutics, Inc. (“Checkpoint”...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.